Status:
COMPLETED
Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Hard Nuclear Cataract
Phacoemulsification Cataract Surgery
Eligibility:
All Genders
50-95 years
Phase:
NA
Brief Summary
In this study, we compared two types of phacoemulsification commonly used in cataract surgery to evaluate their effect on the prognosis of patients with hard nuclei. This will provide a theoretical ba...
Detailed Description
In this study, we randomized patients into two groups. One group was the combined mode group in burst mode and the other group was the torsional ultrasound group in continuous mode. Cumulative dissipa...
Eligibility Criteria
Inclusion
- patients with age-related cataracts that were only classified by Emery-Little as nuclear hardness grade III-V.
- encompassed a minimum dilated pupil diameter of 7 mm or above, as well as a corneal endothelial cell count exceeding 1200/mm\^2.
- Corneal morphology is normal and clear
- Informed consent is required prior to enrollment
Exclusion
- Those with white cataracts, histories of eye surgery, and eye diseases such as corneal pathology, uveitis, Fuchs\' dystrophy, and glaucoma were excluded.
- Exclude those with comorbid ocular and systemic diseases that affect corneal endothelial cell function
- Exclude those with previous intraocular surgery
Key Trial Info
Start Date :
August 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT06991374
Start Date
August 10 2022
End Date
March 1 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye and ENT Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200031